← Back
$ENTA All transactions

ENANTA PHARMACEUTICALS INC

▼ SELL

$ Value

$3K

Shares

207

Price

$14

Filed

Dec 3

Insider

Name

Capps Kathleen S.

Title

See Remarks

CIK

0002085127

Roles

Officer

Transaction Details

Transaction Date

2025-12-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,700

Footnotes

Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021. | Represents shares sold by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 27, 2024, as required pursuant to the terms of the award. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.

Filing Info

Accession No.

0002064832-25-000053

Form Type

4

Issuer CIK

0001177648

Capps Kathleen S.'s History

Date Ticker Type Value
2025-12-05 ENTA $5K
2025-12-02 ENTA $3K
2025-12-01 ENTA F $1K
2025-11-25 ENTA A $0
2025-11-25 ENTA A $0

Other Insiders at ENTA (90d)

Insider Bought Sold Last
CARTER BRUCE L A 2026-03-11
FOLETTA MARK G 2026-03-11
Russell Lesley 2026-03-11
Peterson Kristine 2026-03-11
Luly Jay R.
President and CEO
2026-02-12
Or Yat Sun
Chief Scientific Officer
2026-02-12
Vance Terry 2026-03-11
Hata Yujiro S 2026-03-11
Kowalsky Matthew Paul
Chief Legal Officer
2026-02-12
Kieffer Tara Lynn
Chief Product Strategy Officer
2026-02-12
Luu Brendan
Chief Business Officer
2026-02-12
Rottinghaus Scott T.
Chief Medical Officer
2026-02-12